Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.
Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.
Filter by Form Type:
Industry:Biotechnologyβ
2026-09-10ATNM3SEC Filing Summary for Actinium Pharmaceuticals, Inc.MEDIUM
This filing details changes in beneficial ownership for Steffen Heeger, Chief Medical Officer of Actinium Pharmaceuticals, Inc. Heeger holds 153,868 shares of Common Stock, represented by restricted stock units (RSUs) that vest fully on September 2, 2029. Additionally, he holds stock options to purchase 250,000 shares ...
Nano CapBiotechnology
2026-09-10ATNM3Kamal Adeela - Insider Filing for Actinium Pharmaceuticals, Inc.MEDIUM
This filing details insider transactions for Kamal Adeela, Chief Scientific Officer at Actinium Pharmaceuticals, Inc. It includes information on restricted stock units (RSUs) and stock options. 80,000 RSUs vest in three tranches on September 2, 2027, 2028, and 2029, with the remaining 133,648 RSUs vesting on September ...
Nano CapBiotechnology
2026-09-10CYCN3Power of Attorney for Mark VignolaMEDIUM
This filing is an exhibit containing a Power of Attorney granted by Mark Vignola, Chief Financial Officer of Korsana Biosciences, Inc. The Power of Attorney appoints Kyle Breidenstine, Ryan A. Murr, and Branden Berns as attorneys-in-fact. They are authorized to execute and file Forms 3, 4, and 5 on behalf of Mr. Vignol...
Nano CapBiotechnology
2026-09-10CYCN3Power of Attorney for Nimish ShahMEDIUM
This filing details a Power of Attorney granted by Nimish Shah, a director of Korsana Biosciences, Inc., to specific individuals to act on his behalf regarding SEC filings (Forms 3, 4, and 5). It also provides details on the merger of Korsana Biosciences, Inc. with subsidiaries of Cyclerion Therapeutics, Inc., resultin...
Nano CapBiotechnology
2026-09-10CYCN3Power of Attorney for Michelle PerniceMEDIUM
This filing details a Power of Attorney granted by Michelle Pernice, a director of Korsana Biosciences, Inc., to Mark Vignola and others. The Power of Attorney authorizes the appointees to execute and file Forms 3, 4, and 5 with the SEC on behalf of Ms. Pernice, as required by Section 16(a) of the Securities Exchange A...
Nano CapBiotechnology
2026-09-10CYCN3Form 3 Initial Beneficial Ownership Filing by CMO Matthew Leoni Following Cyclerion/Korsana MergerMEDIUM
This is a Form 3 initial statement of beneficial ownership filed by Matthew Leoni, Chief Medical Officer of Korsana Biosciences, Inc. (formerly Cyclerion Therapeutics, Inc.), with a report date of September 8, 2026. The filing relates to the merger effective September 8, 2026, in which Cariboos Merger Sub Corp. merged ...
Nano CapBiotechnology
2026-09-10CYCN3Form 4 Filing for Jonathan ViolinMEDIUM
This filing details a Form 4 submission by Jonathan Violin, an officer and director of Korsana Biosciences, Inc. (formerly Cyclerion Therapeutics, Inc.). The filing follows a merger effective September 8, 2026, where Cyclerion Therapeutics, Inc. acquired Korsana Biosciences, Inc. (Pre-Merger Korsana). Jonathan Violin r...
Nano CapBiotechnology
Sponsored
2026-09-10Korsana Biosciences, Inc.3Form 3 Initial Beneficial Ownership Filing by CMO Matthew Leoni Following Cyclerion/Korsana MergerDuplicateMEDIUM
This is a Form 3 initial statement of beneficial ownership filed by Matthew Leoni, Chief Medical Officer of Korsana Biosciences, Inc. (formerly Cyclerion Therapeutics, Inc.), with a report date of September 8, 2026. The filing relates to the merger effective September 8, 2026, in which Cariboos Merger Sub Corp. merged ...
Nano CapBiotechnology
2026-09-10Korsana Biosciences, Inc.3Power of Attorney for Michelle PerniceDuplicateMEDIUM
This filing details a Power of Attorney granted by Michelle Pernice, a director of Korsana Biosciences, Inc., to Mark Vignola and others. The Power of Attorney authorizes the appointees to execute and file Forms 3, 4, and 5 with the SEC on behalf of Ms. Pernice, as required by Section 16(a) of the Securities Exchange A...
Nano CapBiotechnology